196 related articles for article (PubMed ID: 26462516)
21. Clinician's guide to human papillomavirus immunology: knowns and unknowns.
Einstein MH; Schiller JT; Viscidi RP; Strickler HD; Coursaget P; Tan T; Halsey N; Jenkins D
Lancet Infect Dis; 2009 Jun; 9(6):347-56. PubMed ID: 19467474
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitination in host immune response to human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Dermatol Res; 2011 May; 303(4):217-30. PubMed ID: 21400034
[TBL] [Abstract][Full Text] [Related]
23. Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection -- review.
Nicol AF; Fernandes AT; Bonecini-Almeida Mda G
Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):1-12. PubMed ID: 15867955
[TBL] [Abstract][Full Text] [Related]
24. HPV vaccines.
Stanley M
Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):279-93. PubMed ID: 16356772
[TBL] [Abstract][Full Text] [Related]
25. Recent progress in vaccination against human papillomavirus-mediated cervical cancer.
McKee SJ; Bergot AS; Leggatt GR
Rev Med Virol; 2015 Mar; 25 Suppl 1():54-71. PubMed ID: 25752816
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in preclinical model systems for papillomaviruses.
Christensen ND; Budgeon LR; Cladel NM; Hu J
Virus Res; 2017 Mar; 231():108-118. PubMed ID: 27956145
[TBL] [Abstract][Full Text] [Related]
27. [Vaccination against human papillomavirus for the prevention of cervical cancer].
Quint WG; ter Harmsel WA; van Doorn LJ
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
[TBL] [Abstract][Full Text] [Related]
28. Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination.
Dillner J; Arbyn M; Dillner L
Clin Exp Immunol; 2007 May; 148(2):199-207. PubMed ID: 17437418
[TBL] [Abstract][Full Text] [Related]
29. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
30. The role of human papilloma virus (HPV) in the aetiology of cervical cancer.
Malik AI
J Pak Med Assoc; 2005 Dec; 55(12):553-8. PubMed ID: 16438278
[No Abstract] [Full Text] [Related]
31. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
32. [Prophylactic and therapeutic vaccination against human papillomavirus].
Brun JL; Riethmuller D
J Gynecol Obstet Biol Reprod (Paris); 2007 Nov; 36(7):631-41. PubMed ID: 17822860
[TBL] [Abstract][Full Text] [Related]
33. Risk factors of invasive cervical cancer in Morocco.
Meftah el khair M; Ait Mhand R; Mzibri ME; Ennaji MM
Cell Mol Biol (Noisy-le-grand); 2009 Nov; 55 Suppl():OL1175-85. PubMed ID: 20003812
[TBL] [Abstract][Full Text] [Related]
34. [Papillomavirus infections and cervical tumorigenesis].
Kiyono T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):227-31. PubMed ID: 20235389
[No Abstract] [Full Text] [Related]
35. Mathematical model of HPV provides insight into impacts of risk factors and vaccine.
Kim JJ
PLoS Med; 2006 May; 3(5):e164. PubMed ID: 16573363
[TBL] [Abstract][Full Text] [Related]
36. HPV Induces Changes in Innate Immune and Adhesion Molecule Markers in Cervical Mucosa With Potential Impact on HIV Infection.
Britto AMA; Goes LR; Sivro A; Policarpo C; Meirelles ÂR; Furtado Y; Almeida G; Arthos J; Cicala C; Soares MA; Machado ES; Giannini ALM
Front Immunol; 2020; 11():2078. PubMed ID: 33013878
[TBL] [Abstract][Full Text] [Related]
37. [Anti-HPV vaccination against cervical cancer].
Simon P; Monnier S; Buxant F; Noël JC
Rev Med Brux; 2005; 26(5):433-8. PubMed ID: 16318096
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus antibody responses among patients with incident cervical carcinoma.
Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
J Med Virol; 1997 Aug; 52(4):436-40. PubMed ID: 9260694
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women.
Sedjo RL; Inserra P; Abrahamsen M; Harris RB; Roe DJ; Baldwin S; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):353-9. PubMed ID: 11927495
[TBL] [Abstract][Full Text] [Related]
40. [Immunologic response to (pre)neoplastic cervical lesions associated with human papillomavirus].
Delvenne P
Bull Mem Acad R Med Belg; 2005; 160(5-6):287-93. PubMed ID: 16465783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
